Obesity and its comorbidities, type 2 diabetes and cardiovascular dis ease, continue to increase in incidence and are major threats to global health. Studies in mice and humans have shown that expansion of adipose tissue mass is closely associated with the recruitment of cells of the myeloid and lymphoid lineage [1] [2] [3] [4] [5] [6] [7] , which gives rise to a state of chronic inflammation. The accumulation of adipose tissue macro phages (ATMs) in obesity is considerable, with ATMs comprising up to 40% of visceral white adipose tissue (VAT) 5 . These cells secrete pro inflammatory molecules, including tumor necrosis factorα (TNFα) 8 , interleukin1β (IL1β) 9, 10 and CCL2 (ref. 11), that contribute to both local and systemic inflammation, thus potentiating insulin resistance. The selective inhibition or genetic deficiency of factors that promote macrophage recruitment (for example, CCL2) or alter their inflamma tory state (for example, IKKβ) reduces adipose tissue inflammation and insulin resistance in obese mice 11, 12 . In human studies, the results of treatment of individuals with type 2 diabetes with the insulinsen sitizing thiazolidinediones showed a correlation between improved systemic insulin resistance and the reduction of ATMs and inflam matory factors 13, 14 . These findings suggest that inflammation of the VAT compromises metabolic homeostasis.
Obesity and its comorbidities, type 2 diabetes and cardiovascular dis ease, continue to increase in incidence and are major threats to global health. Studies in mice and humans have shown that expansion of adipose tissue mass is closely associated with the recruitment of cells of the myeloid and lymphoid lineage [1] [2] [3] [4] [5] [6] [7] , which gives rise to a state of chronic inflammation. The accumulation of adipose tissue macro phages (ATMs) in obesity is considerable, with ATMs comprising up to 40% of visceral white adipose tissue (VAT) 5 . These cells secrete pro inflammatory molecules, including tumor necrosis factorα (TNFα) 8 , interleukin1β (IL1β) 9, 10 and CCL2 (ref. 11) , that contribute to both local and systemic inflammation, thus potentiating insulin resistance. The selective inhibition or genetic deficiency of factors that promote macrophage recruitment (for example, CCL2) or alter their inflamma tory state (for example, IKKβ) reduces adipose tissue inflammation and insulin resistance in obese mice 11, 12 . In human studies, the results of treatment of individuals with type 2 diabetes with the insulinsen sitizing thiazolidinediones showed a correlation between improved systemic insulin resistance and the reduction of ATMs and inflam matory factors 13, 14 . These findings suggest that inflammation of the VAT compromises metabolic homeostasis.
Resident tissue macrophages are a heterogeneous population, and their phenotype and function reflect their local metabolic and immune microenvironment. Macrophages that populate lean adipose tissue are thought to be similar to alternatively activated or M2 macrophages 15 , which characteristically secrete antiinflammatory cytokines (for example, IL10) and promote tissue remodeling. With overnutrition, increased numbers of classically activated or M1like macrophages populate the VAT, where they secrete inflammatory factors that impair glucose homeostasis in this and other tissues 16 . Adipocyte derived chemokines (for example, CCL2 (ref. 17 ) and leukotriene B4 (ref. 18) ) and obesityassociated increases in lipolysis 19 are thought to provoke this influx of inflammatory monocyte-derived macro phages. However, studies have shown that the M1 and M2 macrophage phenotypes are not firmly entrenched, and interventions that alter key signaling molecules controlling alternative activation, such as the peroxisome proliferator activated receptorγ (encoded by Pparg), can regulate the dynamic balance of ATMs and insulin sensitivity 20 .
Despite recent advances in the understanding of the immune cell types that accumulate in adipose tissue with obesity, the underlying mechanisms that promote their accrual and sustain chronic inflam mation are not well understood. We hypothesized that in addition to signals directing the recruitment of macrophages into adipose tissue, obesity provokes signals that promote macrophage retention. And as growing evidence supports roles for neuronal guidance molecules of the slit, semaphorin, ephrin and netrin families in regulating immune cell responses, including migration, adhesion and inflammatory sta tus [21] [22] [23] [24] , it is possible that such molecules have a role in the regula tion of immunometabolism. Indeed, a recent study showed increased expression of semaphorin 3E in the VAT of obese mice and humans, where it promoted the recruitment and activation of macrophages 25 . Notably, such neuronal guidance cues act as both positive and nega tive regulators of cell migration.
Netrin1 is a secreted lamininrelated molecule that orients axonal growth cones through both chemoattractive and chemorepulsive signaling 22 . Netrin1 achieves these opposing functions by engaging distinct receptors on its target cell: receptors of the DCC (deleted in colorectal carcinomas) family, including DCC and neogenin, mediate chemoattraction to netrin1, whereas members of the UNC5 family (UNC5A-UNC5D) and the adenosine A2 B receptor mediate chem orepulsion. Instructional roles for netrin1 and its receptors have been demonstrated in organogenesis 26, 27 , angiogenesis 28, 29 , tumori genesis 30, 31 and inflammation 32, 33 , suggesting that netrin1 regulates cell migration in a broad context. Here we show that netrin1 and its receptor UNC5B (Unc5b in mice) are highly expressed in obese but not lean adipose tissue of humans and mice and investigate the contribution of this guidance cue to highfat diet (HFD)induced inflammation and insulin resistance.
RESULTS

Obesity increases adipose expression of netrin-1 and Unc5b
To identify neuronal guidance cues regulated by obesity, we per formed gene expression profiling of adipose tissue from C57BL/6 mice fed a standard chow or highfat diet (60% kcal) for 20 weeks. Using a custom expression array comprising a complete panel of netrin, semaphorin, slit and ephrin guidance cues and their recep tors, we found that netrin1 (Ntn1) mRNA expression was higher in VAT from HFDfed obese mice than in that from lean chowfed mice (Fig. 1a and Supplementary Table 1) . We confirmed that netrin1 expression was higher in adipose tissue of HFDfed compared to chowfed mice by quantitative RTPCR (qRTPCR) (Fig. 1a) and western blotting (Fig. 1b) but found that serum netrin1 levels were similar in both groups (Supplementary Fig. 1a) . Furthermore, mRNA and protein levels of netrin1 and its chemorepulsive receptor Unc5b were higher in adipose tissue of obese mice compared to lean mice, whereas expression of the chemoattractive receptors Dcc and Neo1 was similar between groups (Fig. 1a,b) . The high expression of Ntn1 and Unc5b in obese adipose tissue was associated with high expression of the macrophage marker F4/80 (Emr1) and the proinflammatory cytokine genes Il6 and Tnf (Fig. 1a) . In addition, the expression of other select neuroimmune guidance molecules was higher in adipose tissue of obese mice compared to lean mice, including of Sema3e (Fig. 1a) , whose gene product was recently reported to promote monocyte recruitment into adipose tissue during HFD feeding 25 .
To identify the cellular compartment expressing netrin1 and Unc5b, we isolated mRNA from the adipocyte and stromal vascu lar fractions of VAT of chow and HFDfed mice and performed qRTPCR analysis. Ntn1 and Unc5b mRNA levels were higher in the stromal vascular but not adipose tissue fraction of HFDfed mice in comparison to that from chowfed mice (Fig. 1c) . Consistent with this, immunofluorescence staining of VAT from HFDfed mice showed netrin1 and Unc5b reactivity in crownlike structures that colocal ized with staining for the macrophage antigen F4/80 (Fig. 1d) . We did npg not detect netrin1 and Unc5b staining in VAT from lean mice (data not shown), which indicates that this guidance cue-receptor pair is specifically expressed in macrophages that infiltrate obese VAT.
To investigate the translational relevance of our findings in mice, we measured the expression of netrin1 and UNC5B in human adi pose tissue from lean (body mass index (BMI) <25 kg/m 2 ) and obese (BMI >28 kg/m 2 ) individuals. NTN1 and UNC5H2 (the homolog of Unc5b) but not DCC mRNA levels were higher in adipose tissue from obese subjects compared to that from lean subjects, as was expres sion of the macrophage marker CD68 and the inflammatory cytokine TNF. SEMA3E expression was also higher in obese compared to lean subjects, whereas mRNA expression for other neuronal guidance cues with immunoregulatory functions, such as SEMA3A, did not vary between obese and lean subjects (Fig. 2a) . Immunofluorescence stain ing showed netrin1 reactivity in adipose tissue from obese, but not lean, individuals that colocalized with CD68positive macrophages in crownlike structures (Fig. 2b) . Notably, netrin1 serum concentra tions were lower in obese (mean BMI 38.6 kg/m 2 ) than in lean (mean BMI 18.2 kg/m 2 ) individuals ( Supplementary Fig. 1b ), suggesting that netrin1 is selectively increased in ATMs during obesity.
Palmitate regulates netrin-1 and Unc5b expression
We next sought to understand the mechanisms underlying ATM expression of netrin1 and Unc5b during obesity. Serum free fatty acids (FFAs) are substantially elevated by HFD feeding and are important adipocytederived mediators of macrophage inflamma tory responses 34, 35 . We tested whether palmitate, a saturated fatty acid that is abundant during obesity, could induce expression of netrin1 and Unc5b in mouse bone marrow-derived macrophages (BMDMs). Ntn1 and Unc5b mRNA expression levels were five and threefold higher, respectively, in BMDMs treated with palmitate conjugated to fatty acid-free BSA than in those treated with BSA alone (Fig. 3a) . Furthermore, palmitate, but not BSA, induced the activity of luciferase reporter genes under control of the NTN1 and UNC5B promoters in human embryonic kidney (HEK) 293T cells; this activity was inhib ited, in part, by pretreating cells with an inhibitor of nuclear factorκB (NFκB), BAY 117085 (Fig. 3b,c) . Moreover, palmitate, but not BSA, induced secretion of netrin1 by BMDMs, as measured by ELISA, and this secretion was inhibited by BAY 117085 (Fig. 3d) .
As a number of studies have demonstrated paracrine interactions between adipocytes and macrophages in the white adipose tissue dur ing inflammation 34 , we next investigated whether adipocyte inflam matory factors secreted during obesity could induce ATM expression of netrin1. We harvested conditioned medium from differentiated 3T3L1 cells treated with palmitate or BSA and used this to treat BMDMs. Secreted factors from palmitatetreated but not BSAtreated adipocytes induced Ntn1 and Unc5b mRNA expression in BMDMs (Fig. 3e) . As previously reported 36, 37 , palmitatetreated adipocytes expressed high levels of Tnf and Il6 mRNA (Fig. 3f) , and treating BMDMs with TNFα or IL6, but not IL4, increased Ntn1 mRNA expression (Fig. 3g) . To test the role of these cytokines, we incubated conditioned medium from palmitate and BSAstimulated differenti ated 3T3L1 cells with blocking antibodies to TNFα and IL6, either alone or in combination, and used it to treat BMDMs. Antibodies to TNFα or IL6, but not control IgG, partially blocked the induction of Ntn1 and Unc5b mRNA expression by conditioned medium from palmitatestimulated adipocytes (Fig. 3h and Supplementary Fig. 2) , supporting a role for adipocytederived TNFα and IL6 in the induc tion of netrin1 and Unc5b in neighboring macrophages.
Netrin-1 promotes defective ATM migration and accumulation As netrin1 has recently been reported to inhibit macrophage migra tion 33 , we hypothesized that its secretion by ATMs may induce macro phage chemostasis and block the egress of these cells from the VAT. To test this, we isolated CD11b + F4/80 + ATMs from mice fed a standard chow diet or HFD for 16 weeks and measured their migration toward the chemokine CCL19, which has been implicated in the emigra tion of tissue macrophages to draining lymph nodes. Notably, ATMs isolated from obese mice exhibited less migration to CCL19 than did ATMs from lean mice (Fig. 4a) , despite their equivalent expression of the CCL19 receptor Ccr7 (Fig. 4b) . By contrast, blood monocytes isolated from lean and obese mice showed similar rates of chemotaxis to CCL2 (Supplementary Fig. 3a) , consistent with reports that circu lating monocytes from chow and HFDfed mice exhibit comparable recruitment to adipose tissue in vivo 38 . Notably, ATMs from lean mice treated with netrin1 showed less migration to CCL19 compared to untreated ATMs (Fig. 4c) . Furthermore, ATMs from obese mice that had been incubated with a blocking antibody to Unc5b were able to migrate toward CCL19 to a similar degree as lean ATMs (Fig. 4d) , which is consistent with a role for netrin1 in the induction of ATM chemostasis during obesity. Moreover, peritoneal macrophages treated with palmitate showed less migration to CCL19 than did BSA treated macrophages (Fig. 4e) . This reduced migration was restored by the addition of a chimeric Unc5bFc peptide that competitively npg inhibits netrin1, but not by addition of a control Fc (Fig. 4f) . We observed similar findings when we used CCL2 as a chemoattractant ( Supplementary Fig. 3b,c) .
On the basis of these data, we postulated that ATM expression of netrin1 during obesity may promote the accumulation of these cells in VAT and foster chronic inflammation and metabolic dysfunction. To test this, we generated mice with and without netrin1 in mac rophages by reconstituting the bone marrow of C57BL/6 mice with fetal liver cells from embryonic day 14 Ntn1 −/− or Ntn1 +/+ (wildtype (WT)) embryos and fed the mice chow or a HFD for 20 weeks. HFD fed Ntn1 −/− →C57BL/6 and WT→C57BL/6 mice gained more weight than their chowfed counterparts; however, we observed no differ ences in food intake (Supplementary Fig. 4a ) or body weight and fat content as measured by dualenergy Xray absorptiometry (Fig. 4g,h ) between the two genotypes. Notably, Ntn1 −/− →C57BL/6 and WT→ C57BL/6 mice fed a chow diet accumulated similar numbers of ATMs, whereas HFDfed Ntn1 −/− →C57BL/6 mice showed lower expression of Emr1 (F4/80) mRNA (Fig. 4i) and fewer F4/80 + cells in crownlike structures (Fig. 4j) in the VAT compared to HFDfed WT→C57BL/6 mice. ATMs isolated from HFDfed Ntn1 −/− →C57BL/6 mice also had lower mRNA expression of proinflammatory cytokines and markers of M1 macrophages (Nos2, Tnf and Il6) and higher mRNA expression of markers of reparative M2 macrophages (Mrc1, Pparg and Il10) com pared with HFDfed WT→C57BL/6 mice (Fig. 5a) . Thus, deletion of hematopoietic Ntn1 reduces ATM accumulation and restores the balance of M1 and M2 macrophages in obese adipose tissue.
To test whether netrin1 affects macrophage mobilization into and out of VAT, we labeled monocytes in vivo with fluorescent beads and tracked them over time 39 . We measured macrophage recruitment and retention in WT→C57BL/6 and Ntn1 −/− →C57BL/6 mice by compar ing the number of beadpositive macrophages that accumulated in VAT 3 d after labeling (the time of peak recruitment of labeled cells to tissues 39 ) and 11 d later to assess the number of labeled macro phages remaining. HFD feeding induced 2.5fold greater recruitment of labeled monocytes into VAT compared to chow feeding in both WT→C57BL/6 and Ntn1 −/− →C57BL/6 mice (Fig. 5b) . The fluores cent beads carried in by these monocytes accumulated within F4/80 positive macrophages present in crownlike structures (Fig. 5c) to a similar extent in HFDfed WT→C57BL/6 and Ntn1 −/− →C57BL/6 mice after 3 d (Fig. 5b) . However, the number of beadlabeled mac rophages in VAT stayed constant in HFDfed WT→C57BL/6 mice at day 14 (Fig. 5b,c) , whereas there were 50% fewer beadlabeled macrophages in VAT of Ntn1 −/− →C57BL/6 mice at this time point compared to day 3. As the reduction in beadlabeled macrophages in the Ntn1 −/− →C57BL/6 mice at day 14 is indicative of ATM emigration from the VAT, we isolated the draining lymph nodes from the mesen tery and analyzed the number of beadlabeled cells in this tissue. The mesenteric lymph nodes of HFDfed Ntn1 −/− →C57BL/6 mice contained 40% more beadlabeled cells compared to WT→C57BL/6 mice at day 14 ( Fig. 5d and Supplementary Fig. 4b) . Together, these data suggest that netrin1 secreted by ATMs acts as a retention signal to promote ATM accumulation in the setting of obesity.
Netrin-1 promotes insulin resistance in vivo
The accumulation of macrophages within VAT has been shown to correlate with systemic inflammation and metabolic dysfunction, and consistent with this, we observed lower serum TNFα concentrations in HFDfed Ntn1 −/− →C57BL/6 mice compared to HFDfed WT→ C57BL/6 mice (Fig. 6a) . Furthermore, glucose and insulin tolerance tests revealed that HFDfed Ntn1 −/− →C57BL/6 mice had improved glucose homeostasis and insulin responsiveness compared to HFDfed WT→C57BL/6 mice (Fig. 6b,c) , as well as lower fasting blood glucose (Fig. 6d) , insulin ( Fig. 6e) and FFA concentrations (Fig. 6f) . Moreover, whereas plasma adiponectin concentrations were lower in HFDfed WT→C57BL/6 mice compared to chowfed mice, no difference was observed between HFDfed and chowfed Ntn1 −/− →C57BL/6 mice (Fig. 6g) . Finally, as the metabolic effects of insulin are dependent on phosphoinositol 3kinase-AKT signaling in target tissues, we measured the phosphorylation of AKT on Ser473 in adipose tissue, liver and mus cle of HFDfed mice. Consistent with the improved insulin sensitivity in Ntn1 −/− →C57BL/6 mice, there was two to fourfold more phospho AKT in adipose tissue, liver and muscle of these mice compared to WT→C57BL/6 controls (Fig. 6h) . Together, these data indicate that loss of netrin1 expression in ATMs leads to improved maintenance of glucose homeostasis and insulin sensitivity during obesity.
DISCUSSION
There is a clear association between ATM accumulation and insu lin resistance with HFD feeding, yet the factors that sustain chronic inflammation in obesity are not well defined. Our results uncover a key role for the neuroimmune guidance cue netrin1 and its receptor Unc5b in the retention of macrophages in the VAT during obesity. The expression of netrin1 and Unc5b proteins is higher in ATMs of obese mice and humans compared to lean controls, where this ligand receptor pair induces macrophage chemostasis. Treating macrophages with palmitate to induce netrin1 secretion or exposing ATMs from lean mice to netrin1 impairs their migration to CCL19, a chemokine that directs the emigration of inflammatory macrophages and den dritic cells from tissues to the lymph nodes. Notably, ATMs isolated from obese mice exhibit impaired migration toward CCL19, which is restored by blocking the netrin1 receptor Unc5b, implicating netrin1 in the induction of ATM chemostasis. Indeed, selective deletion of hematopoietic netrin1 in mice fed a HFD reduces ATM accumula tion in VAT, local and systemic inflammation and insulin resistance. Collectively, these findings suggest that local secretion of netrin1 by ATMs promotes their retention in VAT and the chronic inflammation that leads to metabolic dysfunction.
To understand how netrin1 promotes ATM accumulation in obesity, we adapted a fluorescent bead monocytelabeling technique that has been used to monitor the migration of macrophages into and out of atherosclerotic plaques 39, 40 . In vivo macrophage track ing demonstrated that HFD feeding induces recruitment of threefold more labeled macrophages into the VAT of both WT→C57BL/6 and Ntn1 −/− →C57BL/6 mice compared to chowfed mice of each geno type. Notably, similar numbers of beadlabeled ATMs were detected in VAT of HFDfed WT→C57BL/6 mice after 3 d and 14 d, indicat ing that ATMs recruited to adipose tissue of obese WT mice accrue in the tissue. By contrast, Ntn1 −/− →C57BL/6 mice had 50% fewer beadlabeled ATMs in VAT and a greater number of beadlabeled cells in the mesenteric lymph nodes at day 14 compared to day 3, sug gesting that ATMs emigrate from the VAT in the absence of netrin1. These data suggest that during obesity, netrin1 acts downstream of monocyte chemoattractant signals, such as CCL2, to promote the local retention of ATMs in VAT. Indeed, targeted deletion of netrin1 in hematopoietic cells induces a phenotype similar to that observed in Ccr2 −/− mice 11 : protection from HFD diet-induced adipose tissue inflammation and improved systemic glucose homeostasis and insulin sensitivity.
Studies in humans and animal models have shown that caloric restriction, or a switch from a highfat to a lowfat diet, reduces adi pose tissue inflammation [41] [42] [43] . The signals controlling resolution of inflammation in the adipose tissue remain poorly defined but are likely to involve reduced recruitment, local macrophage death and efferocytosis, as well as egress of macrophages from the inflamma tory site. In other sites, including the intestine 44 and atherosclerotic plaques 40, 45 , the chemokine receptor CCR7 has been shown to pro mote the trafficking of macrophages to the lymph nodes. We show herein that ATMs isolated from obese but not lean mice exhibit impaired migration to the CCR7 ligand CCL19, despite their equiva lent expression of CCR7. Notably, the responsiveness to CCL19 could be restored in obese ATMs by inhibiting the Unc5b receptor, suggest ing that netrin1 is responsible for this chemostasis. Previous studies npg have shown that netrin1 inhibits Racmediated reorganization of the actin cyctoskeleton and cell spreading, key steps required for cell migration 33 . Although the signaling pathways regulating netrin1 expression in ATMs of obese mice and humans in vivo will require further experimentation, previous studies have shown that increased FFA concentrations promote macrophage accumulation in the VAT 19 . Indeed, we demonstrate that palmitate directly induces Ntn1 and Unc5b expression by macrophages and also upregulates expression of TNFα and IL6 by neighboring adipocytes, which in turn can induce macrophage Ntn1 and Unc5b expression.
Collectively, our studies suggest a model in which netrin1 secreted by ATMs in the setting of obesity acts as a 'stop' signal to promote the accrual of these immune cells in the VAT. Macrophages, as a percent age of total cells in the VAT, expand from ~10% in lean individuals to more than 50% in those with advanced obesity, yet the underly ing cause and functions of these ATMs remain poorly understood. A number of hypotheses regarding the triggers of ATM accumulation have been put forth, including an increase in adipocyte death in the expanding adipose tissue 46 , the release of saturated FFAs that activate inflammatory signaling pathways 47, 48 and the need for macrophages to buffer the lipids released from obese adipocytes in order to pro tect tissues from potentially toxic lipid levels 49 . These signals, either alone or combined, promote the sustained accumulation of ATMs and inflammatory molecules that impair the metabolic function of the VAT. We postulate that netrin1 may be turned on as a signal to locally trap ATMs during obesity to help the VAT in the clearance of apoptotic adipocytes and the buffering of increased lipids; however, its sustained expression leads to chronic inflammation and the failure to reestablish tissue homeostasis.
It is notable that netrin1 is selectively upregulated in the VAT, but not the serum, of obese mice and humans. In fact, we observed a modest but significant reduction in circulating levels of netrin1 in obese individuals compared to lean controls and a similar trend in HFDfed mice. Although the implications of these findings are unknown, recent studies have suggested that netrin1 in the circula tion may inhibit inflammation by reducing leukocyte recruitment into tissues. Netrin1 is expressed on vascular endothelium and gut epithe lium, where its expression is regulated to promote or inhibit leuko cyte transmigration into tissues 32, [50] [51] [52] . Reduced circulating levels of netrin1 have been associated with neutrophil infiltration of the kid ney during ischemiareperfusion injury 53, 54 . Furthermore, lentiviral overexpression of netrin1 on endothelial cells protects Ldlr −/− mice from atherosclerosis 55 , presumably by reducing leukocyte recruitment into the artery wall. However, netrin1 is also abundantly expressed by macrophage foam cells in atherosclerotic plaques, where its expres sion promotes the accumulation of macrophages and disease progres sion 33 , consistent with our findings in obese VAT. Thus, therapeutic targeting of netrin1 to reduce chronic inflammation in obesity and atherosclerosis will require macrophagetargeted delivery of netrin1 or Unc5b inhibitors to avoid unwanted effects on netrin1 at the endothelium or epithelium.
Current strategies aimed at targeting adipose tissue inflammation have so far yielded variable results: blocking TNFα signaling in obese individuals with type 2 diabetes produced suboptimal outcomes 56 , yet clinical trials involving inhibition of IL1 signaling appear more promising 57 . However, these therapies directed at blocking cytokines that result from chronic inflammation are likely to be less effective than treatments targeting the source of this problem, i.e., the sus tained accumulation of macrophages and other immune cells in VAT. Our work suggests that targeting local factors that promote the retention of macrophages, such as the netrin1-Unc5b axis, may reverse the local and systemic mediators of inflammation that drive metabolic dysfunction.
METHODS
Methods and any associated references are available in the online version of the paper. 
